Dopamine, immunity, and disease

B Channer, SM Matt, EA Nickoloff-Bybel, V Pappa… - Pharmacological …, 2023 - ASPET
The neurotransmitter dopamine is a key factor in central nervous system (CNS) function,
regulating many processes including reward, movement, and cognition. Dopamine also …

The interplay between HIV and COVID-19: summary of the data and responses to date

LB Brown, MA Spinelli, M Gandhi - Current Opinion in HIV and …, 2021 - journals.lww.com
Conclusion COVID-19 is threatening gains against the HIV epidemic, including the US
Ending the HIV Epidemic goals. The ongoing collision of these two global pandemics will …

Sociodemographic factors and social determinants associated with toxicology confirmed polysubstance opioid-related deaths

JA Barocas, J Wang, BDL Marshall… - Drug and alcohol …, 2019 - Elsevier
Background and aims While prescribed and illicit opioid use are primary drivers of the
national surges in overdose deaths, opioid overdose deaths in which stimulants are also …

Worldwide relative smoking prevalence among people living with and without HIV

PI Johnston, SW Wright, M Orr, FA Pearce, JW Stevens… - Aids, 2021 - journals.lww.com
Objective and design: People living with HIV (PLH) suffer disproportionately from the chronic
diseases exacerbated by smoking tobacco. We performed a systematic review and meta …

[HTML][HTML] Co-receptor signaling in the pathogenesis of neuroHIV

EA Nickoloff-Bybel, L Festa, O Meucci, PJ Gaskill - Retrovirology, 2021 - Springer
The HIV co-receptors, CCR5 and CXCR4, are necessary for HIV entry into target cells,
interacting with the HIV envelope protein, gp120, to initiate several signaling cascades …

[HTML][HTML] mHealth interventions to promote anti-retroviral adherence in HIV: narrative review

SB Lee, J Valerius - JMIR mHealth and uHealth, 2020 - mhealth.jmir.org
Background Antiretrovirals (ARVs) are key in the management of HIV. Although no cure
exists, ARVs help patients live healthy lives and prevent transmission to others. Adherence …

[HTML][HTML] The association between marijuana use and HIV continuum of care outcomes: a systematic review

LT Montgomery, K Bagot, JL Brown… - Current HIV/AIDS …, 2019 - Springer
Abstract Purpose of Review Approximately 77% of HIV-infected adults report lifetime
marijuana use. Given the high rates and social acceptability of marijuana use among HIV …

[HTML][HTML] Effects of acute cannabidiol on behavior and the endocannabinoid system in HIV-1 Tat transgenic female and male mice

BJ Yadav-Samudrala, BL Gorman… - Frontiers in …, 2024 - frontiersin.org
Background Some evidence suggests that cannabidiol (CBD) has potential to help alleviate
HIV symptoms due to its antioxidant and anti-inflammatory properties. Here we examined …

[HTML][HTML] Neurological, Behavioral, and Pathophysiological Characterization of the Co-Occurrence of Substance Use and HIV: A Narrative Review

L Vines, D Sotelo, N Giddens, P Manza, ND Volkow… - Brain Sciences, 2023 - mdpi.com
Combined antiretroviral therapy (cART) has greatly reduced the severity of HIV-associated
neurocognitive disorders in people living with HIV (PLWH); however, PLWH are more likely …

Closing the gaps in the continuum of depression care for persons with HIV: modeling the impact on viral suppression in the United States

LJ Koenig, N Khurana, MH Islam, C Gopalappa… - Aids, 2023 - journals.lww.com
Objective: Depression is prevalent among persons with HIV (PWH) and is associated with
poorer adherence and lack of viral load suppression (VLS). When treated for depression …